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Coronavirus E protein is a small viral envelope protein that plays an essential role in coronavirus assembly; coexpression
of coronavirus M and E proteins results in the production of virus-like particles. The present study demonstrated that mouse
hepatitis virus (MHV) E protein was released as an integral membrane protein in lipid vesicles from E-protein-expressing
mammalian cells, in the absence of other MHV proteins. Furthermore, our data indicated that the E-protein-containing
vesicles, which had a slightly lighter buoyant density than that of MHV, were released from MHV-infected cells. These data
implied that E protein alone can drive the production and release of coronavirus envelope in the absence of M protein. © 1999
Academic Press
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ositive-stranded RNA genome. The coronavirus enve-
ope typically contains three virus-specific proteins: S, M,
nd E. The S protein forms 180- to 90-kDa peplomers,
inds receptors on coronavirus-susceptible cells, and
nduces cell fusion. The M protein, a transmembrane
rotein, is the most abundant glycoprotein in infected
ells as well as in the virus particle. The M protein has
hree domains; these include a short N-terminal ectodo-
ain, a triple-spanning transmembrane domain, and a
-terminal endodomain. The E protein, previously re-
erred to as the small membrane protein or sM protein, is
n acylated protein and is present only in minute
mounts in infected cells as well as in the virus enve-
ope. The structure inside the viral envelope is a helical
ucleocapsid that consists of viral RNA and N protein.
ach coronavirus-specific protein is translated from
ach of six to eight species of virus-specific mRNAs that
ave a 39-coterminal nested set structure (1).
E protein is crucial to coronavirus assembly. Coex-
ression of coronavirus M protein and E protein results
n the production of virus-like particles (VLPs), while
xpression of M protein alone does not produce VLPs
2–4). Complementation studies using two defective in-
erfering (DI) RNAs of a prototypic coronavirus, mouse
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Microbiology and Immunology, The Univer-
ity of Texas Medical Branch at Galveston, Galveston, TX 77551-1019.cax: (409) 772-5065. E-mail: shmakino@utmb.edu.
265epatitis virus (MHV), showed that E and M proteins are
oth required for the production of MHV particles con-
aining the viral nucleocapsid (5). E protein also plays a
ole in coronavirus morphogenesis, because MHV mu-
ants encoding mutated E protein are morphologically
berrant compared to wild-type MHV (6). Even though
he importance of E protein in coronavirus assembly is
nown, more detailed characterization of its function has
een limited because of its very low abundance in the
irus and in infected cells. In infected cells E protein has
een shown to be an integral membrane protein (3), yet
ts presence as an integral membrane protein in virus
articles has not been demonstrated. The orientation of
protein in the membrane is also unknown.
In the present study we demonstrated that E-protein-
ontaining membrane vesicles were released from E-
rotein-expressing cells. Furthermore, our data indicated
hat the E-protein-containing membrane vesicles were
eleased from MHV-infected cells. These data were un-
xpected, because M protein is also considered essen-
ial for coronavirus envelope formation. The data pre-
ented here suggest the possibility that E protein alone
an drive the production and release of the coronavirus
nvelope in the absence of M protein.
We used a Sindbis virus expression vector, pSinRep5
7) (Invitrogen, San Diego, CA), to express MHV E protein
nd M protein at high levels in mammalian cells. This
ector contains a promoter for subgenomic transcription
nd the Sindbis virus nonstructural protein genes 1–4
hat are required for replication of vector RNAs. We
onstructed one Sindbis vector that expressed MHV M
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266 RAPID COMMUNICATIONrotein (pSinM) and another that expressed MHV E pro-
ein (pSinE) by respectively inserting gene 6 (encoding
he M protein) from the JHM strain of MHV (MHV-JHM)
nd gene 5b (encoding the E protein) from the A59 strain
f MHV (MHV-A59) downstream of the promoter for sub-
enomic transcription. Sindbis vector expressing MHV-
HM E protein was also constructed. However, expres-
ion of E protein from this vector was significantly lower
han that from pSinE (data not shown). For this reason,
SinE was used for subsequent studies. RNA transcripts
rom these plasmids were synthesized in vitro and each
NA was mixed with the Sindbis helper transcript,
H(26S), which contains the genes for Sindbis virus
tructural proteins (8). When DH(26S) RNA transcripts
re cotransfected with the recombinant RNA from pSin-
ep5, expression of the structural proteins in trans from
H(26S) RNA transcripts allows the packaging of recom-
inant RNA into virions (pseudovirions) (7). Because
H(26S) lacks a Sindbis virus packaging signal, DH(26S)
NA is not packaged into pseudovirions.
A mixture of pSinM RNA transcripts and DH(26S) and
nother of pSinE RNA transcripts and DH(26S) were
ndependently transfected into BHK cells using electro-
oration (7). As a control, DH(26S) and RNA transcripts of
SinRep/LacZ (Invitrogen) encoding the lacZ gene were
otransfected. Culture fluid was collected 30 h after
ransfection and then inoculated into DBT cells. Cells
ere metabolically labeled with 50–100 mCi of Tran35S-
abel (ICN) from 6.5 to 7 h postinoculation for labeling of
protein and from 5 to 7 h postinoculation for labeling
f E protein. The cell lysates were prepared with lysis
uffer [150 mM NaCl, 50 mM Tris–HCl (pH 7.5), 1% Triton
-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl
ulfate, and 1 mM phenylmethylsulfonyl fluoride]. Radio-
mmunoprecipitation analysis of cell extracts from the
ells that were inoculated with the culture fluid from cells
otansfected with pSinM transcripts and DH(26S) and
rom cells cotransfected with pSinE transcripts and
H(26S), respectively, showed excellent expression of M
nd E proteins (Fig. 1). MHV M protein, N protein, and an
nknown protein (shown by an asterisk in Fig. 1) were
lso coimmunoprecipitated by anti-E protein peptide-2
ntibody (9) under these experimental conditions. Anti-E
rotein antibody did not immunoprecipitate expressed
HV M and N proteins (unpublished data), eliminating
he possibility that anti-E protein antibody cross-reacts
ith M and N proteins. Coimmunoprecipitation of M and
proteins in MHV-infected cells by anti-E protein anti-
ody most likely indicated the interaction of viral struc-
ural proteins in MHV-infected cells. b-Galactosidase
taining of DBT cells at 7 h postinoculation of the culture
luid from the cells cotransfected with pSinRep/LacZ
ranscripts and DH(26S) demonstrated a high level of
xpression of b-galactosidase (data not shown). These
ata demonstrated that pseudovirions carrying pSinE
NA transcripts (SinE pseudovirions), pSinM RNA tran- fcripts (SinM pseudovirions), and pSinRep/LacZ tran-
cripts (SinLacZ pseudovirions) were released from the
ells that were cotransfected with DH(26S) and pSinE
ranscripts, DH(26S) and pSinM transcripts, and DH(26S)
nd pSinRep/LacZ transcripts, respectively. Infection of
seudovirions and subsequent replication of recombi-
ant vector RNA resulted in a high level of expression of
loned proteins in DBT cells (Fig. 1).
To determine whether E protein is released from the
-protein-expressing cells, SinE pseudovirion-infected
BT cells were radiolabeled with Tran35S-label from 5 to
h p.i. As controls, DBT cells were infected with SinM
seudovirions alone or coinfected with SinM pseudoviri-
ns and SinE pseudovirions. Culture fluid was harvested
t 9 h p.i. and briefly centrifuged to remove cell debris.
ulture media were applied onto a discontinuous su-
rose gradient consisting of 20 and 60% sucrose in NTE
uffer [100 mM NaCl, 10 mM Tris–HCl (pH 7.5), and 1 mM
DTA]. After centrifugation at 26,000 rpm for 15 h at 4°C
n a Beckman SW28 rotor, the interface between 20 and
0% sucrose was collected and diluted threefold with
TE buffer. The sample was further purified by the 20–
0% continuous sucrose gradient centrifugation at
6,000 rpm for 15 h at 4°C in a Beckman SW28 rotor. Ten
ractions were collected from the bottom of the gradient
nd an equal amount of 23 lysis buffer was added to
ach fraction. M and E proteins in each of the sucrose
FIG. 1. Analysis of intracellular MHV proteins after infection of SinM
nd SinE pseudovirions. DBT cells were mock infected or infected with
ecombinant Sindbis pseudovirions. Intracellular proteins were labeled
ith Tran35S-label for from 6.5 to 7 h p.i. (A) or from 5 to 7 h p.i. (B).
ntracellular proteins were immunoprecipitated with anti-M protein
onoclonal antibody J.2.7. (A) or anti-E protein peptide-2 antibody (B).
noculum: SinM pseudovirion, lane 2; SinLacZ pseudovirion, lanes 3, 6;
inE pseudovirion, lane 5; MHV-A59, lane 7; mock infection, lane 8.
anes 1 and 4, 14C-labeled protein size marker.ractions were immunoprecipitated with a mixture of
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267RAPID COMMUNICATIONnti-M protein monoclonal antibody J.2.7 (10) and anti-E
rotein peptide-2 antibody (9). No M protein signal was
etected in the culture fluid from SinM pseudovirion-
nfected DBT cells (data not shown). From the cells
oexpressing M and E proteins, both M and E proteins
ere detected in three sucrose fractions (Fig. 2A). These
esults were expected; expression of M protein alone
oes not produce VLPs, while coexpression of M and E
roteins produce VLPs (2–4). Characterization of culture
luids from coexpressing cells showed that the distribu-
ions of M and E proteins in the gradient were not
dentical; the major M protein signal was in fractions 6
nd 7, while the major E protein signal was in fractions 7
nd 8; M protein signal in fractions 6 and 7 was about
00 times higher than that in fraction 8 and the E protein
ignal in fractions 7 and 8 was about 15 times higher
han that in fraction 6. To our surprise, E protein was
eleased into the culture supernatant from E-protein-
xpressing cells (Fig. 2B). The released E protein sedi-
ented to a sucrose density of about 1.13 g/cm3, which
as slightly lighter than the major signal of M protein
density 1.16–1.14 g/cm3) released from coinfected cells;
he relative intensity of E protein signal in fractions 7–9
as 2, 4.3, and 1, respectively. The presence of E protein
n culture fluid was not due to the release of an intracel-
ular form of E protein as a result of cellular disruption,
ince no cytopathic effects were detected in SinE
seudovirion-infected DBT cells at 9 h p.i. In coexpress-
ng cells, we saw a slightly different distribution of E and
proteins in the sucrose gradient (Fig. 2A), indicating
hat VLPs, containing M and E proteins and free E pro-
ein, not associated with M protein, were released into
he culture media.
To know whether the release of E protein from E-pro-
ein-expressing cells was an artifact of the expression
ystem, release of E protein from MHV-infected cells was
xamined. MHV-A59-infected cells were radiolabeled
ith Tran35S-label from 5 to 9 h p.i. The culture fluid was
ollected and MHV was purified on a 20–60% continuous
ucrose gradient under the same conditions as de-
cribed above. MHV structural proteins in each fraction
ere immunoprecipitated with a mixture of anti-MHV
erum, anti-M protein monoclonal antibody, and anti-E
rotein antibody (Fig. 3A). MHV S protein, N protein, and
protein appeared in a single radioactive peak that
orresponded to a sucrose density of 1.18 g/cm3, which is
he buoyant density of MHV particles (11). E protein had
wo radioactive peaks, one corresponded to the MHV
uoyant density of 1.18g/cm3 and the other peak had a
ensity of about 1.13 g/cm3, which was similar to the
ensity of released E protein from E-protein-expressing
ells. These data suggested that E protein that was not
ssociated with MHV particles was released from MHV-
nfected cells. A different centrifugation condition was
sed to further confirm the release of E protein from
35HV-infected cells. S-labeled culture fluid from DBT Aells, which were infected with MHV-A59 or SinE
seudovirions, was collected 9 h p.i., as described
bove, and then applied onto a discontinuous sucrose
radient consisting of 20 and 60% sucrose in NTE buffer.
FIG. 2. Release of E protein from E-protein-expressing cells. DBT
ells were coinfected with SinM and SinE pseudovirions (A) or infected
ith SinE pseudovirion (B). Cells were radiolabeled with Tran35S-label
rom 5 to 9 h p.i. Released VLPs or E-protein-containing vesicles were
urified by sucrose gradient centrifugation, as described in the text. M
nd E proteins in each fraction were immunoprecipitated with a mixture
f anti-M protein monoclonal antibody and anti-E protein antibody. The
4C-labeled size marker is shown on the left of each gel.fter centrifugation at 26,000 rpm for 15 h at 4°C in a
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268 RAPID COMMUNICATIONeckman SW28 rotor, the interface between 20 and 60%
ucrose was collected and diluted threefold with NTE
uffer. The sample was layered over a 10–30% continu-
us sucrose gradient, with a 60% sucrose cushion at the
ottom of the gradient. The gradients were centrifuged at
0,000 rpm for 1 h at 4°C in a Beckman SW41 rotor.
welve fractions were collected from the bottom of the
radient and MHV structural proteins in each fraction
ere immunoprecipitated with a mixture of anti-MHV
erum, anti-M protein monoclonal antibody, and anti-E
rotein antibody. Densitometric analysis of N protein in
he sample from MHV-infected cells showed a single
adioactive peak in fraction 4 with a sucrose density of
.15 g/cm3 (Fig. 3B). MHV M and S proteins also had a
ingle radioactive peak in fraction 4 (data not shown),
emonstrating that fraction 4 represented the major MHV
eak. Radioactive signal of E protein, which was broader
han that of N protein, had two peaks. One of the peak
ignals was in the heavier fraction 4; this signal most
robably represented E protein in MHV particles. The
ther peak signal of E protein had a lighter density of
bout 1.11 g/cm3. Under the same centrifugation condi-
ion, released E protein from the E-protein-expressing
ells had a single radioactive peak in fractions 6 and 7;
he densities of sucrose in fractions 6 and 7 were 1.12
nd 1.11 g/cm3, respectively (Fig. 3C). E protein released
rom the E-protein-expressing cells and the E protein
ignal from MHV-infected cells, corresponding to the
ighter density, had very similar sucrose densities. Es-
entially the same result was obtained in three indepen-
ent experiments. These results strongly indicated that E
rotein that was not associated with MHV particles was
eleased from MHV-infected cells.
To establish the buoyant density of released E protein,
ulture fluids from E-protein-expressing cells were ap-
lied onto a discontinuous sucrose gradient and centri-
uged as described above. The interface between 20 and
0% sucrose was collected, diluted, and separated again
n a 10–30% continuous sucrose gradient at 30,000 rpm
n a Beckman SW40 rotor at 4°C for 1, 3, 6, or 12 h.
adioimmunoprecipitation of E protein from the sucrose
ractions showed that released E protein sedimented to
ucrose densities of 1.10–1.13 g/cm3 after 1 h centrifuga-
ion. Released E protein sedimented to a sucrose density
f about 1.13 g/cm3 after 3 h centrifugation, and longer
entrifugation did not affect the sedimentation profile
data not shown); these data demonstrated that the buoy-
nt density of E protein was about 1.13g/cm3. The re-
eased E protein had a narrow distribution in the sucrose
radients under all the described centrifugation condi-
ions (data not shown).
We conducted flotation analysis to determine whether
he E protein was released, from the E-protein-express-
ng cells, as a membrane protein in vesicles or as a
ecreted protein. The E protein released from SinE
seudovirion-infected cells was partially purified by dis- pontinuous sucrose gradient centrifugation. Sucrose
rystals were added to the partially purified E protein to
final concentration of 67% sucrose, and the sample
as placed at the bottom of a centrifuge tube. Subse-
uently, 5 ml of 65% sucrose and 3 ml of 10% sucrose
olutions were overlaid onto the 67% sucrose solution.
he gradients were centrifuged at 35,000 rpm for 18 h at
°C, and fractions were collected from the top of the
radient. Radioimmunoprecipitation of E protein by
nti-E protein antibody determined that most of the E
FIG. 3. Release of E protein from MHV-infected cells. DBT cells were
nfected with MHV (A, B) or SinE pseudovirion (C). The density of the
ucrose fractions is shown at the top of each panel. (A) Culture media
rom MHV-infected cells, which were radiolabeled with Tran35S-label
rom 5 to 9 h p.i., were applied onto a discontinuous sucrose gradient
onsisting of 20 and 60% sucrose and centrifuged at 26,000 rpm for
5 h at 4°C in a Beckman SW28 rotor. The interface between 20 and
0% sucrose was collected, diluted, and then applied onto a 20–60%
ontinuous sucrose gradient. After centrifugation at 26,000 rpm for 15 h
t 4°C in a Beckman SW28 rotor, fractions were collected and MHV-
pecific proteins in each fraction were immunoprecipitated with a
ixture of anti-MHV serum, anti-M protein monoclonal antibody, and
nti-E protein antibody. The 14C-labeled size marker is shown on the left
f the gel. (B, C) MHV-infected cells (B) or E-protein-expressing cells (C)
ere radiolabeled with Tran35S-label from 5 to 9 h p.i. Culture medium
as then applied onto a discontinuous sucrose gradient consisting of
0 and 60% sucrose and centrifuged at 26,000 rpm for 15 h at 4°C in a
eckman SW28 rotor. The interface between 20 and 60% sucrose was
ollected, diluted, and layered over a 10–30% continuous sucrose
radient with a 60% sucrose cushion at the bottom of the gradient. The
amples were centrifuged at 30,000 rpm for 1 h at 4°C in a Beckman
W41 rotor. Twelve fractions were collected and MHV structural pro-
eins in each fraction were immunoprecipitated with a mixture of
nti-MHV serum, anti-M protein monoclonal antibody, and anti-E pro-
ein antibody. Portions of gels showing N and E proteins (B) and E
rotein (C) are shown. Relative intensities of N protein (triangles) and
protein (open boxes) are also shown.rotein settled at the interface between 65 and 10%
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269RAPID COMMUNICATIONucrose, which indicated that the E protein had migrated
rom the 67% sucrose solution to the interface during
entrifugation (Fig. 4A). When NP-40 was added to the
7% sucrose solution at a final concentration of 1% and
he same flotation analysis was performed, the majority
f E protein was detected in the 65–67% sucrose frac-
ions (Fig. 4A). In flotation analysis, membrane-associ-
ted proteins localize at the interface of 65 and 10%
ucrose and soluble proteins remain in the heavier su-
rose loading zone of the gradient (12). Therefore, these
FIG. 3ata demonstrated that released E protein was associ- tted with lipid membrane vesicles and that NP-40 treat-
ent disrupted this association.
Next we used a sodium carbonate treatment method
o determine whether the E protein was released as an
ntegral membrane protein. Culture fluids from E-protein-
xpressing cells were incubated in 100 mM Na2CO3 at
H 11 for 30 min on ice. As a control, the culture fluid was
ncubated in a buffer containing no Na2CO3 at pH 7.0.
odium carbonate treatment disrupts membrane vesi-
les, releasing the peripheral membrane proteins from
inuedhese vesicles, while integral membrane proteins are not
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270 RAPID COMMUNICATIONffected (3, 13). After incubation, the samples were cen-
rifuged at 50,000 rpm for 1 h at 4°C in a Beckman SW50
otor. E protein was present in the pellet after both alkali
reatment and the neutral pH treatment (Fig. 4B), leading
s to conclude that E protein was released as an integral
embrane protein in lipid vesicles.
The release of E-protein-containing membrane vesi-
les from MHV-infected cells and E-protein-expressing
ells further emphasized the pivotal role of E protein in
oronavirus assembly. Other examples, where expres-
ion of a single viral protein results in production and
elease of lipid vesicles, exist: the Gag protein of Rous
arcoma virus (RSV) and the M protein of vesicular sto-
atitis virus (VSV) both have the ability to bud from cells
ndependently of other viral proteins (14, 15). Recent
tudies indicate that a proline-rich motif found within the
SV M protein and the RSV Gag protein interacts with
W domains of cellular proteins (16, 17, 18) and this
nteraction may be important for virus budding (18, 19).
FIG. 4. Released E protein exists as an integral membrane protein in
he sucrose fraction containing partially purified E-protein-containing ve
% NP-40 (NP-40) and overlaid with 65 and 10% sucrose. After centrifu
nti-E protein antibody. Fraction 11, fractions 6–10, and fractions 1–4
nterface between 65 and 10% sucrose. The 14C-labeled 14-kDa size m
esicles after sodium carbonate treatment. Culture fluid from E-protein
(lane 2) for 30 min on ice. After incubation, the samples were centrifu
as immunoprecipitated with anti-E protein antibody. Lane 1, the 14C-lhe WW domain is a highly structured, modular domain pf 38–40 amino acids that facilitates protein–protein in-
eractions. The WW domain is present in a wide variety of
ellular proteins with diverse functions and consists of a
ydrophobic pocket that is flanked by two perfectly con-
erved tryptophan (W) residues (16). Involvement of the
W domain of some host protein in budding of MHV
-protein-containing vesicles seems less likely, as MHV
protein lacks the proline-rich motif found in rhabdovi-
uses and RSV. Nevertheless, some host protein may
ossibly interact with E protein and this interaction may
rive the budding of coronavirus. VSV and RSV bud from
he cytoplasmic membrane, while coronavirus buds from
n internal compartment between the endoplasmic re-
iculum and the Golgi apparatus; cellular protein(s) that
ocalizes at the budding site may affect coronavirus bud-
ing.
Although E protein is a major player in coronavirus
nvelope formation and budding, E protein alone may be
nsufficient for nucleocapsid incorporation into the virus
anous vesicles. (A) Flotation analysis of E-protein-containing vesicles.
was adjusted to 67% sucrose in NTE (NTE) or 67% sucrose in NTE plus
fractions were collected and E protein was immunoprecipitated using
ent 67, 65, and 10% sucrose, respectively. Fraction 5 represents the
is shown on the left of each gel. (B) Analysis of E-protein-containing
sing cells was incubated in 100 mM Na2CO3 at pH 11 (lane 3) or pH
50,000 rpm for 1 h at 4°C in a Beckman SW50 rotor. Pelleted protein
14-kDa size marker.membr
sicles
gation
repres
arker
-expres
ged atarticles. Earlier we established a complementary DI
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271RAPID COMMUNICATIONystem, in which MHV particles are released after coin-
ection of two DI RNAs; one is a self-replicating DI RNA
ncoding viral polymerase function and N protein, and
he other subgenomically expressing M and E proteins
5). Release of MHV particles containing nucleocapsid
equires synthesis of both E and M proteins in the com-
lementary DI system (5). Presumably, in the comple-
entary DI system E-protein-containing vesicles were
eleased from the cells, in which self-replicating DI RNA
nd another DI RNA encoding only E protein were rep-
icated. We know that no MHV nucleocapsid was de-
ected in the supernatant (5), suggesting that E-protein-
ontaining vesicles may not include nucleocapsid. Fur-
hermore, sucrose gradient centrifugation of MHV
articles showed two E protein radioactive peaks,
hereas N protein had only one peak corresponding to
he MHV buoyant density (Fig. 3), indicating that mem-
rane vesicles containing only E protein do not include
ucleocapsid. Another envelope protein, S protein, is not
nvolved in the incorporation of the nucleocapsid, be-
ause MHV particles containing nucleocapsid are pro-
uced in the absence of S protein (5). Most probably, M
rotein functions to incorporate nucleocapsid into virus
articles. Likely, M protein interacts with the nucleocap-
id and E protein at the coronavirus budding site, and
hese intermolecular interactions facilitate the envelop-
ent of the nucleocapsid. Data demonstrating that puri-
ied M protein and viral RNA interact in vitro (20) and that
protein and nucleocapsid interact in MHV-infected
ells (Narayanan, Maeda, Maeda, and Makino, unpub-
ished data) support this model. This model is also con-
istent with the present data that M, N, and E proteins
ere coimmunoprecipitated by anti-E protein antibody in
HV-infected cells (Fig. 1B).
VLPs that are made of M and E proteins are morpho-
ogically similar to coronavirus particles (3, 4), whereas
he morphology of E-protein-containing vesicles is not
nown. Poor production of E-protein-containing vesicles
n E-protein-expressing cells and a lack of anti-E protein
onoclonal antibodies which are suitable for immuno-
old-labeling studies are the main obstacles in determin-
ng the shape of E-protein-containing vesicles. Charac-
erization of E-protein-containing vesicles is important. If
-protein-containing vesicles and MHV particles have
imilar sizes and morphologies, then E protein alone
ay determine the size and shape of coronavirus parti-
les. If E-protein-containing vesicles are significantly dif-
erent from MHV particles in size and shape, then per-
aps M protein is important for the determination of the
ize and morphology of coronavirus particles.
E-protein-containing vesicles were released from
HV-infected cells (Fig. 3), demonstrating that the pro-
uction of E-protein-containing vesicles was not an arti-
act of the expression system. Probably E-protein-con-
aining vesicles are also produced in coronavirus-in-
ected humans and animals. Do E-protein-containingesicles have any biological functions? Recently Bau-
oux et al. (4) showed that VLPs that are made of coro-
avirus transmissible gastroenteritis virus (TGEV) M and
proteins can induce a-interferon in leukocytes. Their
tudy suggests that M protein in VLP is important for
-interferon induction. Further studies will show whether
HV E-protein-containing vesicles have any biological
unctions.
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